Kefunova is exactly what dermatology providers have been asking for-a trusted, high-quality option to target actinic keratosis and superficial basal ...

SKNV, a leader in dermatologic innovation and custom prescription medications, proudly announces the launch of Kefunova Cream ...

Objectives: This study aimed to evaluate the effectiveness of deep learning model in assisting dermatologists in classifying basal cell carcinoma (BCC ... causing a blend of colors. Superficial red ...

SkinJect Inc. a wholly owned subsidiary of Medicus Pharma Ltd, is a development stage, life sciences company focused on commercializing novel, non-invasive treatment for basal cell skin cancer using ...

Several components of the hedgehog (Hh) pathway are crucial to basal cell carcinoma (BCC) tumorigenesis. Primary cilia have emerged as key organelles in Hh signal transduction in mammalian systems ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Now visualized using cryo-electron microscopy, the carrier’s lock-like mechanism could be the key to tackling diseases like cancer, diabetes ... it needs to be transferred inside the cell’s ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

A new discovery could pave the way for more effective cancer treatment by helping certain ... to improve their ability to slip through cell membranes by passive diffusion. But the new strategy ...

they were able to deliver between 7.7 and 22.3 times more of the drug into cancer cells – making the treatment up to 23 times more effective, according to a study published today (April 17) in Cell.

Researchers found pyronaridine disrupts an enzyme critical to cellular division and can cause cancer cell death. Additionally, the drug has not been shown to cause significant adverse events in ...